During a presentation at the American College of Clinical Endocrinology annual meeting, Linda A
The window for market entry remains open partly due to persistent supply constraints among current manufacturers and partly because the addressable patient population continues expanding as clinical evidence mounts for GLP-1 benefits across obesity, diabetes, MASH, cardiovascular disease, and other indications
So next time you're reaching for a snack, reach for one thats working for you behind the scenes
But there are several reasons you might want to consider adding an electrolyte drink or supplement of some sort to your routine
was supported by a Wellcome Trust Clinical Research Training Fellowship
For the GLP-1 RA cohort, we followed the same protocol as previously described, but excluded those who had ever been co-prescribed an SGLT2i at any time